GENE ONLINE|News &
Opinion
Blog

2022-07-28|

BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka

by GeneOnline
Share To

The opening session of BIO-Asia Taiwan 2022 featured a presentation by Professor Shinya Yamanaka from Japan. Prof. Yamanaka, who was awarded the Nobel Prize in Physiology and Medicine in 2012 for his iPSC research, discussed the future vision of popularizing iPSC technology with the title “Top iPS Cell Technologies at Affordable Prices”.

CiRA’s Three Major Strategies for Accelerated Production of iPSC

The CiRA Foundation (Center for iPS Cell Research Application, Kyoto University), a leading regenerative medicine research institute in Japan, was established through the efforts of Prof. Yamanaka to shorten the gap between research and industry in iPSC technology. CiRA has three main strategies to facilitate the advancement of therapeutic applications of iPSC.

It's free! Log in now to read

LATEST
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
Exosomes: The Small Couriers Moving Beyond Traditional Drug Delivery
2025-04-17
Trump Administration’s CDC Layoffs Shutter STD Lab, Sending Ripples Through Biotech and Global Health
2025-04-17
Fake Ozempic Floods Market as FDA Warns Patients to Check Authenticity of Prescriptions
2025-04-16
NIH Facing $20 Billion Budget Cut and Potential Consolidation in 2026
2025-04-16
Trump Administration Budget Proposal Includes $20 Billion Cut to NIH by 2026 and Agency Reorganization
2025-04-16
Robert F. Kennedy Jr.’s Proposed Budget Prioritizes Public Health, Environmental Protection, and Healthcare Reform
2025-04-16
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
Scroll to Top